The health insurance giant has called a new report from WSJ “misinformation,” but investors may not be so sure. Shares were ...

This is part three of a 13-part series about companies whose shares have amassed 100,000% returns for investors and the path ...

NEW YORK, NY / ACCESS Newswire / February 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ...

UnitedHealth Group’s stock plummets after DOJ investigation report - UnitedHealth Group have had a tumultuous past year, ...

Argus has a "buy" rating and $115 price target for STT stock, which closed at $98.61 on Feb. 11. Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 4.83% to 5.83%.